Mangostin inhibits the oxidative modification of human low density lipoprotein.

P. Williams, M. Ongsukul, Julie Proudfoot, Kevin Croft, Lawrence Beilin

Research output: Contribution to journalArticlepeer-review

109 Citations (Scopus)


The oxidation of low density lipoprotein (LDL) may play an important role in atherosclerosis. We investigated the possible antioxidant effects of mangostin, isolated from Garcinia mangostana, on metal ion dependent (Cu2+) and independent (aqueous peroxyl radicals) oxidation of human LDL. Mangostin prolonged the lagtime to both metal ion dependent and independent oxidation of LDL in a dose dependent manner over 5 to 50 mu M as monitored by the formation of conjugated dienes at 234nm (P <0.001). There was no significant effect of mangostin on the rate at which conjugated dienes were formed in the uninhibited phase of oxidation. Levels of thiobarbituric reactive substances (TBARS) generated in LDL were measured 4 and 24 hours after oxidation with 5 mu M Cu2+ in the presence or absence of 50 mu M or 100 mu M mangostin. We observed an inhibition of TBARS formation with 100 mu M mangostin at 4 hours (P = 0.027) but not at 24 hours (P = 0.163). Similar results were observed in the presence of 50 mu M mangostin. Mangostin, at 100 mu M, retarded the relative electrophoretic mobility of LDL at both 4 and 24 hours after Cu2+ induced oxidation. Mangostin (100 mu M) significantly inhibited the consumption of a-tocopherol in the LDL during Cu2+ initiated oxidation over a 75 minute period (P <0.001). From these results, we conclude that mangostin is acting as a free radical scavenger to protect the LDL from oxidative damage in this in vitro system.
Original languageEnglish
Pages (from-to)175-184
JournalFree Radical Research
Issue number2
Publication statusPublished - 1995


Dive into the research topics of 'Mangostin inhibits the oxidative modification of human low density lipoprotein.'. Together they form a unique fingerprint.

Cite this